Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Ligand (LGND) Breakout!

16 Jan 2019 01:34 PM <--

12 Sep 1996 12:53 PM

Return to Ligand (LGND) Breakout!

home.att.net

Today LGND made a major announcement at the Bear Stearns' Biotech
conference this morning. One of LGND's retinoids, Targretin, is in advanced
clinical trials for a wide range of cancers. Today LGND indicated
that pre-clinical data (in mice and rats) suggested additional
indications (for type II diabetes and breast cancer). Over 1/2
million shares traded in the first hour and the price has moved
to 15 1/4 (from yesterday's close of 13 1/8).

Henry N Fox Chapel